INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $291,000 | -38.5% | 4,000 | 0.0% | 0.28% | -10.9% |
| Q4 2021 | $473,000 | -11.9% | 4,000 | 0.0% | 0.31% | +8.3% |
| Q3 2021 | $537,000 | -17.1% | 4,000 | 0.0% | 0.29% | -25.6% |
| Q2 2021 | $648,000 | +34.4% | 4,000 | -33.3% | 0.39% | +9.9% |
| Q1 2021 | $482,000 | +47.9% | 6,000 | 0.0% | 0.35% | +8.3% |
| Q4 2020 | $326,000 | +63.0% | 6,000 | -14.3% | 0.32% | +200.9% |
| Q3 2018 | $200,000 | -53.7% | 7,000 | -55.7% | 0.11% | -66.6% |
| Q2 2018 | $432,000 | +213.0% | 15,800 | +119.4% | 0.32% | +226.3% |
| Q4 2017 | $138,000 | – | 7,200 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |